Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Dec 27, 2017 (9 years ago)

Labetalol HCl in 0.9% Sodium Chloride in all strengths

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of sterility assurance.

Cause type: Sterility / contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections. All sterility / contamination recalls.

What was recalled

Labetalol HCl in 0.9% Sodium Chloride in all strengths, all doses, and all packaging.

Drug: Labetalol

Recalling firm
Pharmedium Services, LLC
Origin
IL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0460-2018 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Labetalol recalls

See all
Class II · Moderate risk

PF-Labetalol HCl Injection

CGMP Deviations: Potential for cross contamination due to product carry over.

Terminated Cross-contamination Nephron Sterile Compounding Center LLC NDC 69374-946-34 D-0064-2023
Class II · Moderate risk

PF-Labetalol HCl Injection

CGMP Deviations: Potential for cross-contamination due to product carryover during manufacturing.

Terminated Cross-contamination Nephron Sterile Compounding Center LLC NDC 69374-946-34 D-1347-2022

Other recalls by Pharmedium Services, LLC

All 2017 recalls